Study on applying qbd approach to microbial limit tests on non-sterile pharmaceutical products
- At: 2018 FIP Congress in Glasgow (Scotland)
- Type: Poster
- By: AKSU, Buket (İSTANBUL KEMERBURGAZ University, Pharmaceutical Technology)
- Co-author(s): Buket Aksu: Faculty of Pharmacy, Altınbaş University, Istanbul, Turkey
Gizem Yegen: Faculty of Pharmacy, Altınbaş University, Istanbul, Turkey
Cansu Vatansever: Faculty of Pharmacy, Altınbaş University, Istanbul, Turkey
Microorganisms can cause spoilage in pharmaceutical products and are potential hazard to patients. Thus, certain tests must be conducted to demonstrate that pharmaceutical products are within the safety microbial limits (1). In QbD (Quality by Design) studies, it is important to determine the critical quality attributes (CQAs) and.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.